Diagnostic Kit for Quantitative Carbohydrate Antigen 125

Short Description:

Uncut sheet for Blood Quantitative Carbohydrate Antigen 125

Fluorescence Immunochromatographic Assay


  • Testing time: 15 minutes
  • Storage temperature: 2°C-30°C
  • Valid Time: 24 months
  • Accurancy: More than 99%
  • Specification: 25 test/box
  • Methodology: Fluorescence Immune
  • Product Detail

    Product Tags

    1. Usage

    This kit is applicable to in vitro quantitative detection of Carbohydrate Antigen 125 (CA 125) in human serumsamples. The kit only provides test result of Carbohydrate Antigen 125 (CA 125) . The obtained result shall be analyzed in combination with other clinical information. It must only be used by healthcare professionals.

    2. PRODUCT SPECIFICATION

    Model No. CA125
    Methodology  Fluorescence Immunochromatographic Assay
    Sample Type serum/plasma
    Time to Result 10-15mins
    Storage 2~30 ℃/36~86℉
    Shelf Life 24 months 
    Certificate ISO13485
    25-(OH)VD-3
    25-(OH)VD-2
    MAIN KIT COMPONENTS:
    *Test device
    *solution
    *Instructions for Use
    Packing:
    *25 test /kit
    *Aluminum foil bag labeling
    *shrink wrap

    3.TEST METHOD

    1 Read the instruction for use and test operation manual completely before the test and restore the reagent to room
    temperature before the test. Do not perform the test without restoring the reagent to room temperature to avoid
    affecting the accuracy of the test results.
    2 Select standard test mode of WIZ-A101 portable immune analyzer
    3 Open the aluminum foil bag package of reagent, and take out the test device;
    4 Horizontally insert the test device into the slot of immune analyzer;
    5 On home page of operation interface of immune analyzer, click “Standard” to enter test interface;
    6 Click “QC Scan” to scan the QR code on inner side of the kit; input kit related parameters into instrument, and select sample type;
    Note: Each batch number of the kit shall be scanned for one time. If the batch number has been scanned, then skip this step;
    7 Check the consistency of “Product Name”, “Batch Number” etc. on test interface with information on the kit label;
    8 After information consistency is confirmed, take out sample diluents, add 80µL of serum/plasma  sample, and sufficiently mix;Add 80µL of above mixed solution into the sample hole of test device;
    9 After complete sample addition, click “Timing” and remaining test time will be automatically displayed on the interface.
    10  Immune analyzer will automatically complete test and analysis when test time is reached.
    11 Result calculation and display
    After test by immune analyzer is completed, test result will be displayed on test interface or can be viewed through “History” on home page of operation interface.

    4.Importance of CA125 Detection

    Carbohydrate Antigen 125, commonly known as CA125, is a widely used serum tumor marker. CA125 testing plays a vital role in clinical management, especially for gynecological conditions.

    1

    Auxiliary Screening for Ovarian Cancer

    CA125 is the most classic biomarker associated with epithelial ovarian cancer. Elevated CA125 levels can provide an early warning signal, helping clinicians identify high-risk individuals. It is particularly valuable for people with a family history of ovarian cancer or other related risk factors. It should be noted that CA125 alone cannot be used as a definitive diagnostic basis for ovarian cancer.

    2

    Monitoring Treatment Response

    For patients diagnosed with ovarian cancer, serial CA125 testing is a key method to evaluate therapeutic effects. A falling CA125 level usually indicates a favorable response to surgery, chemotherapy or other treatments. Persistently high or rising CA125 may suggest residual lesions or poor treatment efficacy.

    3

    Early Detection of Disease Recurrence

    After completing standard treatment, regular CA125 follow-up testing helps detect tumor recurrence at an early stage, often before obvious clinical symptoms or imaging abnormalities appear. Timely discovery of recurrence creates more opportunities for subsequent intervention.

    4

    Differential Diagnosis of Pelvic Masses

    When abnormal pelvic masses are found by ultrasound or other imaging examinations, CA125 detection assists doctors in distinguishing between benign lesions and malignant tumors. Many benign conditions such as endometriosis, pelvic inflammatory disease, ovarian cysts, and pregnancy can also lead to mild CA125 elevation, so combined judgment with clinical symptoms and other examinations is required.

    5

    Prognostic Reference Indicator

    The baseline CA125 level before treatment is an important reference for assessing the prognosis of ovarian cancer patients. Higher baseline values are generally linked to more advanced disease stages and relatively poorer prognosis.

    .

    5. CERTIFICATE

    * ISO System Certificate

    * CE Certificate

    * EU Registration

    * UCKA MHRA Registration


  • Previous:
  • Next:

  • Related Products